Leading Radiology Forward

Favorable Revenue Mix Mitigates Reimbursement Risk Emphasis placed on multi-modality strategy • "One-stop-shopping" for referral sources • Lessens exposure to reimbursement changes, diversifies revenue base Extensive offering of all routine imaging procedures partially insulates us from reimbursement cuts, which generally impact MRI, CT and PET/CT modalities disproportionately. X-Ray 25.4% PET/CT 0.6% RadNet. Q4 2020 Scan Volume by Modality Nuclear Medicine Other 5.4% 0.5% MRI .14.0% CT 8.7% Ultrasound 24.1% Mammo 21.4% Q4 2020 Net Revenue by Modality(1) PET/CT 5.6% X-Ray 6.7% Ultrasound 12.4% Mammo 17.8% Nuclear Medicine Other 4.9% 1.0% MRI 34.8% CT 16.9% Leading Radiology Forward 14

View entire presentation